Clinical Trial Update: Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study

View source ↗

Summary

A real-world evidence study assessing efficacy and safety of JAK inhibitors in patients with Alopecia Areata, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Janus Kinase Inhibitors

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Alopecia Areata, Janus Kinase Inhibitors | Status: RECRUITING